ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
hottod
|
87 |
42K |
102 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
87
|
42K
|
102
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
24 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update - Amended
|
|
hottod
|
23 |
6.8K |
38 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
23
|
6.8K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
82 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
1.2K
|
673K
|
82
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q2 2024 update
|
|
hottod
|
61 |
27K |
53 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
61
|
27K
|
53
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q2 2024 update
|
|
hottod
|
61 |
27K |
143 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
61
|
27K
|
143
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.2K |
1.4M |
30 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.2K
|
1.4M
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
816 |
377K |
29 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
816
|
377K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
32 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
32
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
14 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
12K
|
6.2M
|
14
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Trading Result (unaudited)
|
|
hottod
|
189 |
61K |
74 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
189
|
61K
|
74
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
816 |
377K |
27 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
816
|
377K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
128 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
1.2K
|
673K
|
128
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
18 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
18
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
29 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
29
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
hottod
|
35 |
23K |
26 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
35
|
23K
|
26
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change in substantial holding
|
|
hottod
|
28 |
9.1K |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
28
|
9.1K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.2M |
34 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
11K
|
5.2M
|
34
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2024 Quarterly Activities Report & Appendix 4C
|
|
hottod
|
123 |
30K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
123
|
30K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Extension of RP11 Single Dose Study Into Multiple Dose Study
|
|
hottod
|
6 |
2.2K |
24 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
6
|
2.2K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.2M |
29 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
11K
|
5.2M
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
hottod
|
32 |
15K |
27 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
32
|
15K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren receives Rare Pediatric Disease Designation from FDA
|
|
hottod
|
32 |
15K |
52 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
32
|
15K
|
52
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
23 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
hottod
|
71 |
40K |
27 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
40K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
hottod
|
71 |
40K |
17 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
71
|
40K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
816 |
377K |
26 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
816
|
377K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
816 |
377K |
38 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
816
|
377K
|
38
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
12K |
6.2M |
21 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
12K
|
6.2M
|
21
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
hottod
|
55 |
21K |
20 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
55
|
21K
|
20
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
hottod
|
55 |
21K |
31 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
55
|
21K
|
31
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
11K |
5.2M |
100 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
11K
|
5.2M
|
100
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
hottod
|
55 |
21K |
32 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
55
|
21K
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
35 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
1.2K
|
673K
|
35
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
439 |
202K |
28 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
439
|
202K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Final Director's Interest Notice - T Scott
|
|
hottod
|
7 |
4.6K |
8 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
7
|
4.6K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
16 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
673K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
13 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
673K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
24 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
1.2K
|
673K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Question for holders about exclusivity.
|
|
hottod
|
13 |
5.3K |
59 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
13
|
5.3K
|
59
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Drug Candidate Safe and Well Tolerated
|
|
hottod
|
5 |
3.0K |
8 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
5
|
3.0K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
56 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
56
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
4 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
47 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
47
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
54 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
54
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
4 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.2K |
673K |
64 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
1.2K
|
673K
|
64
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
hottod
|
131 |
61K |
17 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
131
|
61K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
816 |
377K |
37 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
816
|
377K
|
37
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
hottod
|
131 |
61K |
34 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
131
|
61K
|
34
|
|